vs
CATO CORP(CATO)与REPLIGEN CORP(RGEN)财务数据对比。点击上方公司名可切换其他公司
REPLIGEN CORP的季度营收约是CATO CORP的1.3倍($197.9M vs $155.4M),REPLIGEN CORP净利率更高(6.7% vs -3.3%,领先10.1%),REPLIGEN CORP同比增速更快(13.6% vs 6.3%),REPLIGEN CORP自由现金流更多($17.6M vs $-12.9M),过去两年REPLIGEN CORP的营收复合增速更高(14.4% vs -5.7%)
凯拓集团(Cato Corporation)是美国女性时装及配饰零售商,总部位于北卡罗来纳州夏洛特市。截至2016年1月,该公司旗下共运营1372家门店,覆盖Cato、Cato Plus、It's Fashion、It's Fashion Metro与Versona多个品牌。
Repligen是一家全球生命科学企业,专注于创新生物工艺技术与系统的研发及商业化,助力提升生物药生产效率。公司1981年成立,总部位于美国马萨诸塞州沃尔瑟姆,于纳斯达克挂牌上市,股票代码RGEN,截至2025年全球员工超1900人,主要服务生物制药领域客户。
CATO vs RGEN — 直观对比
营收规模更大
RGEN
是对方的1.3倍
$155.4M
营收增速更快
RGEN
高出7.3%
6.3%
净利率更高
RGEN
高出10.1%
-3.3%
自由现金流更多
RGEN
多$30.5M
$-12.9M
两年增速更快
RGEN
近两年复合增速
-5.7%
损益表 — Q3 FY2026 vs Q4 FY2025
| 指标 | ||
|---|---|---|
| 营收 | $155.4M | $197.9M |
| 净利润 | $-5.2M | $13.3M |
| 毛利率 | 32.7% | 52.5% |
| 营业利润率 | -5.3% | 9.0% |
| 净利率 | -3.3% | 6.7% |
| 营收同比 | 6.3% | 13.6% |
| 净利润同比 | 65.6% | 143.9% |
| 每股收益(稀释后) | $-0.28 | $0.24 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
CATO
RGEN
| Q4 25 | $155.4M | $197.9M | ||
| Q3 25 | $176.5M | $188.8M | ||
| Q2 25 | $170.2M | $182.4M | ||
| Q1 25 | $157.9M | $169.2M | ||
| Q4 24 | $146.2M | $174.1M | ||
| Q3 24 | $168.6M | $154.9M | ||
| Q2 24 | $177.1M | $154.1M | ||
| Q1 24 | $174.9M | $151.3M |
净利润
CATO
RGEN
| Q4 25 | $-5.2M | $13.3M | ||
| Q3 25 | $6.8M | $14.9M | ||
| Q2 25 | $3.3M | $14.9M | ||
| Q1 25 | $-14.1M | $5.8M | ||
| Q4 24 | $-15.1M | $-30.3M | ||
| Q3 24 | $95.0K | $-654.0K | ||
| Q2 24 | $11.0M | $3.3M | ||
| Q1 24 | — | $2.1M |
毛利率
CATO
RGEN
| Q4 25 | 32.7% | 52.5% | ||
| Q3 25 | 36.8% | 53.2% | ||
| Q2 25 | 35.8% | 50.0% | ||
| Q1 25 | 29.2% | 53.6% | ||
| Q4 24 | 29.6% | 26.1% | ||
| Q3 24 | 35.3% | 50.0% | ||
| Q2 24 | 36.5% | 49.8% | ||
| Q1 24 | 32.1% | 49.5% |
营业利润率
CATO
RGEN
| Q4 25 | -5.3% | 9.0% | ||
| Q3 25 | 3.1% | 8.9% | ||
| Q2 25 | 2.0% | 7.6% | ||
| Q1 25 | -15.2% | 3.9% | ||
| Q4 24 | -11.6% | -17.7% | ||
| Q3 24 | -0.4% | -5.1% | ||
| Q2 24 | 3.5% | 1.0% | ||
| Q1 24 | -9.5% | 1.3% |
净利率
CATO
RGEN
| Q4 25 | -3.3% | 6.7% | ||
| Q3 25 | 3.9% | 7.9% | ||
| Q2 25 | 1.9% | 8.2% | ||
| Q1 25 | -8.9% | 3.4% | ||
| Q4 24 | -10.3% | -17.4% | ||
| Q3 24 | 0.1% | -0.4% | ||
| Q2 24 | 6.2% | 2.2% | ||
| Q1 24 | — | 1.4% |
每股收益(稀释后)
CATO
RGEN
| Q4 25 | $-0.28 | $0.24 | ||
| Q3 25 | $0.35 | $0.26 | ||
| Q2 25 | $0.17 | $0.26 | ||
| Q1 25 | $-0.73 | $0.10 | ||
| Q4 24 | $-0.79 | $-0.55 | ||
| Q3 24 | $0.01 | $-0.01 | ||
| Q2 24 | $0.54 | $0.06 | ||
| Q1 24 | $-1.15 | $0.04 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $79.0M | $767.6M |
| 总债务越低越好 | — | $542.2M |
| 股东权益账面价值 | $167.6M | $2.1B |
| 总资产 | $450.2M | $2.9B |
| 负债/权益比越低杠杆越低 | — | 0.26× |
8季度趋势,按日历期对齐
现金及短期投资
CATO
RGEN
| Q4 25 | $79.0M | $767.6M | ||
| Q3 25 | $90.8M | $748.7M | ||
| Q2 25 | $80.0M | $708.9M | ||
| Q1 25 | $77.7M | $697.2M | ||
| Q4 24 | $86.2M | $757.4M | ||
| Q3 24 | $104.7M | $784.0M | ||
| Q2 24 | $105.4M | $809.1M | ||
| Q1 24 | $103.0M | $780.6M |
总债务
CATO
RGEN
| Q4 25 | — | $542.2M | ||
| Q3 25 | — | $537.9M | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $525.6M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益
CATO
RGEN
| Q4 25 | $167.6M | $2.1B | ||
| Q3 25 | $172.2M | $2.1B | ||
| Q2 25 | $164.9M | $2.1B | ||
| Q1 25 | $162.3M | $2.0B | ||
| Q4 24 | $177.1M | $2.0B | ||
| Q3 24 | $195.1M | $2.0B | ||
| Q2 24 | $196.9M | $2.0B | ||
| Q1 24 | $192.3M | $2.0B |
总资产
CATO
RGEN
| Q4 25 | $450.2M | $2.9B | ||
| Q3 25 | $436.9M | $2.9B | ||
| Q2 25 | $440.8M | $2.9B | ||
| Q1 25 | $452.4M | $2.9B | ||
| Q4 24 | $424.4M | $2.8B | ||
| Q3 24 | $455.6M | $2.8B | ||
| Q2 24 | $477.1M | $2.9B | ||
| Q1 24 | $486.8M | $2.8B |
负债/权益比
CATO
RGEN
| Q4 25 | — | 0.26× | ||
| Q3 25 | — | 0.26× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.27× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $-12.4M | $25.7M |
| 自由现金流经营现金流 - 资本支出 | $-12.9M | $17.6M |
| 自由现金流率自由现金流/营收 | -8.3% | 8.9% |
| 资本支出强度资本支出/营收 | 0.3% | 4.1% |
| 现金转化率经营现金流/净利润 | — | 1.93× |
| 过去12个月自由现金流最近4个季度 | $-7.5M | $93.9M |
8季度趋势,按日历期对齐
经营现金流
CATO
RGEN
| Q4 25 | $-12.4M | $25.7M | ||
| Q3 25 | $11.8M | $48.1M | ||
| Q2 25 | $3.9M | $28.6M | ||
| Q1 25 | $-6.5M | $15.0M | ||
| Q4 24 | $-22.1M | $39.2M | ||
| Q3 24 | $3.1M | $49.3M | ||
| Q2 24 | $5.7M | $42.2M | ||
| Q1 24 | $-11.2M | $44.7M |
自由现金流
CATO
RGEN
| Q4 25 | $-12.9M | $17.6M | ||
| Q3 25 | $10.4M | $43.4M | ||
| Q2 25 | $2.8M | $21.5M | ||
| Q1 25 | $-7.8M | $11.4M | ||
| Q4 24 | $-23.8M | $33.6M | ||
| Q3 24 | $1.6M | $42.3M | ||
| Q2 24 | $2.4M | $37.4M | ||
| Q1 24 | $-13.5M | $36.4M |
自由现金流率
CATO
RGEN
| Q4 25 | -8.3% | 8.9% | ||
| Q3 25 | 5.9% | 23.0% | ||
| Q2 25 | 1.7% | 11.8% | ||
| Q1 25 | -5.0% | 6.8% | ||
| Q4 24 | -16.3% | 19.3% | ||
| Q3 24 | 0.9% | 27.3% | ||
| Q2 24 | 1.4% | 24.3% | ||
| Q1 24 | -7.7% | 24.0% |
资本支出强度
CATO
RGEN
| Q4 25 | 0.3% | 4.1% | ||
| Q3 25 | 0.8% | 2.5% | ||
| Q2 25 | 0.6% | 3.9% | ||
| Q1 25 | 0.9% | 2.1% | ||
| Q4 24 | 1.2% | 3.2% | ||
| Q3 24 | 0.9% | 4.5% | ||
| Q2 24 | 1.8% | 3.1% | ||
| Q1 24 | 1.3% | 5.5% |
现金转化率
CATO
RGEN
| Q4 25 | — | 1.93× | ||
| Q3 25 | 1.72× | 3.23× | ||
| Q2 25 | 1.17× | 1.92× | ||
| Q1 25 | — | 2.57× | ||
| Q4 24 | — | — | ||
| Q3 24 | 32.95× | — | ||
| Q2 24 | 0.52× | 12.70× | ||
| Q1 24 | — | 21.35× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CATO
| Retail Segment | $154.7M | 100% |
| Credit Card | $5.3M | 3% |
RGEN
暂无分部数据